Reuters logo
BRIEF-Kalobios to have FDA meeting for using benznidazole to treat Chagas disease
December 5, 2016 / 12:47 PM / a year ago

BRIEF-Kalobios to have FDA meeting for using benznidazole to treat Chagas disease

Dec 5 (Reuters) - Kalobios Pharmaceuticals Inc :

* Kalobios Pharmaceuticals Inc - “expect to have an FDA meeting to confirm regulatory pathway for benznidazole in treatment of Chagas disease”

* Kalobios Pharmaceuticals Inc - to continue enrolling patients in company’s ongoing phase 1 study of lenzilumab for chronic myelomonocytic leukemia

* Kalobios Pharmaceuticals Inc - to explore partnering other proprietary monoclonal antibodies (MABS), such as ifabotuzumab

* Says work on benznidazole program has accelerated since co acquired rights in June 2016 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below